Screener
McKesson MCK North American Pharmaceutical — Other adjustments
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by McKesson in its filing.
Tagged under the XBRL concept us-gaap:GoodwillPurchaseAccountingAdjustments.
The source filing: McKesson’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 5:29 PM EDT
- Fiscal quarter
- Q1 FY2027
- Calendar quarter
- Q2 2026
- Accession
- 0000927653-26-000234
| (In millions) | North American Pharmaceutical | Oncology & Multispecialty | Prescription Technology Solutions | Medical-Surgical Solutions | Total |
|---|---|---|---|---|---|
| Balance, March 31, 2026 | $2,781 | $3,963 | $2,065 | $2,507 | $11,316 |
| Goodwill acquired | — | 13 | — | — | 13 |
| Disposals | — | (2) | — | — | (2) |
| Foreign currency translation adjustments, net | (26) | — | — | — | (26) |
| Other adjustments (1) | — | (23) | — | — | (23) |
| Balance, June 30, 2026 | $2,755 | $3,951 | $2,065 | $2,507 | $11,278 |
Item 1. Condensed Consolidated Financial Statements.
FAQ
- What is McKesson's north american pharmaceutical — other adjustments?
- McKesson (MCK) reported north american pharmaceutical — other adjustments of $0 in Q2 2026.
- What does north american pharmaceutical — other adjustments mean?
- Various non-recurring or non-operational adjustments applied to the North American pharmaceutical segment's financial results to reflect underlying performance. These adjustments often include restructuring costs, severance, or specific accounting reclassifications.
Ask your AI about McKesson's north american pharmaceutical — other adjustments.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude